Published in Science on June 10, 1994
Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc Natl Acad Sci U S A (1989) 1.97
Complementary-addressed (sequence-specific) modification of nucleic acids. Prog Nucleic Acid Res Mol Biol (1985) 1.87
Health care, medical practice, and medical ethics in Russia today. JAMA (1995) 1.76
Tertiary structure of tRNAs in solution monitored by phosphodiester modification with ethylnitrosourea. Eur J Biochem (1981) 1.56
Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3'-terminus and their interaction with DNA within mammalian cells. FEBS Lett (1989) 1.35
Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy. Bioelectrochemistry (2002) 1.35
Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation. Br J Cancer (2006) 1.32
Interaction of tRNAPhe and tRNAVal with aminoacyl-tRNA synthetases. A chemical modification study. Eur J Biochem (1983) 1.13
Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Chemical aspects. Adv Enzyme Regul (1985) 1.06
Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes. Nucleic Acids Res (1999) 0.98
Complementary addressed modification and cleavage of a single stranded DNA fragment with alkylating oligonucleotide derivatives. Nucleic Acids Res (1986) 0.98
Site-specific cleavage of single-stranded DNAs at unique sites by a copper-dependent redox reaction. Nature (1988) 0.95
RNase T1 mimicking artificial ribonuclease. Nucleic Acids Res (2007) 0.95
Synthetic RNA-cleaving molecules mimicking ribonuclease A active center. Design and cleavage of tRNA transcripts. Nucleic Acids Res (1993) 0.91
Sequence-specific chemical modification of a 365-nucleotide-long DNA fragment with an alkylating oligonucleotide derivative. FEBS Lett (1985) 0.90
Structural arrangement of tRNA binding sites on Escherichia coli ribosomes, as revealed from data on affinity labelling with photoactivatable tRNA derivatives. Biochim Biophys Acta (1989) 0.89
Porphyrin-linked oligonucleotides. Synthesis and sequence-specific modification of ssDNA. FEBS Lett (1990) 0.89
Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Biochemical aspects. Adv Enzyme Regul (1985) 0.86
Chemical and computer probing of RNA structure. Prog Nucleic Acid Res Mol Biol (1996) 0.86
Reactive oligonucleotide derivatives and sequence-specific modification of nucleic acids. Biochimie (1986) 0.86
The tertiary structure of yeast tRNAPhe in solution studied by phosphodiester bond modification with ethylnitrosourea. FEBS Lett (1980) 0.86
Protection of phosphodiester bonds in yeast tRNAVal by its cognate aminoacyl-tRNA synthetase against alkylation by ethylnitrosourea. FEBS Lett (1981) 0.86
Antisense oligonucleotide derivatives as gene-targeted drugs. Biomed Sci (1990) 0.85
Hybridization of antisense oligonucleotides with the 3'part of tRNA(Phe). FEBS Lett (1999) 0.85
Cleavage of RNA with synthetic ribonuclease mimics. Methods Enzymol (2000) 0.85
Secondary structure of the 5'-region of PGY1/MDR1 mRNA. FEBS Lett (2000) 0.85
Cleavage of RNA by an amphiphilic compound lacking traditional catalytic groups. Bioorg Chem (2007) 0.84
Nucleic acids in exosomes: disease markers and intercellular communication molecules. Biochemistry (Mosc) (2013) 0.84
Cell membranes as barriers for antisense constructions. Antisense Res Dev (1992) 0.83
Cleavage of yeast tRNAPhe with complementary oligonucleotide conjugated to a small ribonuclease mimic. FEBS Lett (2000) 0.83
Extracellular DNA in culture of primary and transformed cells, infected and not infected with mycoplasma. Bull Exp Biol Med (2009) 0.81
Silencing of MDR 1 gene in cancer cells by siRNA. Nucleosides Nucleotides Nucleic Acids (2004) 0.81
Reactive oligonucleotide derivatives as gene-targeted biologically active compounds and affinity probes. Genetica (1991) 0.80
Alkylation of tRNATrp in a complex with tryptophanyl-tRNA synthetase. FEBS Lett (1978) 0.80
Deoxyribonuclease activity in biological fluids of healthy donors and cancer patients. Bull Exp Biol Med (2008) 0.80
Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups. Biochimie (1993) 0.79
c-fos gene expression in cell revertants from a transformed to a pseudonormal phenotype. FEBS Lett (1993) 0.79
Expression of the MDR1 and MRP genes in patients with lymphoma with primary bone marrow involvement. Nucleosides Nucleotides Nucleic Acids (2004) 0.79
Interaction of oligonucleotides with barrier fluid proteins. Biochemistry (Mosc) (1997) 0.79
Rapid sequence-independent cellular response to oligodeoxynucleotides. FEBS Lett (1997) 0.78
Ribonuclease activity of the peptides with alternating arginine and leucine residues conjugated to tetrathymidilate. Nucleosides Nucleotides Nucleic Acids (2004) 0.78
A Comparison of Target Gene Silencing using Synthetically Modified siRNA and shRNA That Express Recombinant Lentiviral Vectors. Acta Naturae (2009) 0.78
Antiproliferative and interferon-inducing activities of unique short double-stranded RNA. Dokl Biochem Biophys (2011) 0.78
Structural studies by high-field NMR spectroscopy of a binary-addressed complementary oligonucleotide system juxtaposing pyrene and perfluoro-azide units. J Biomol Struct Dyn (1997) 0.77
Evidence from chemical modification for an unusual tertiary structure of the TpseudouridineC loop in rabbit liver tRNA1Val. FEBS Lett (1978) 0.77
Serum immunoglobulins interact with oligonucleotides. FEBS Lett (1994) 0.77
Interaction of LNA oligonucleotides with mdr1 promoter. Nucleosides Nucleotides Nucleic Acids (2001) 0.77
Nuclear peptides specifically interacting with oligonucleotides. Nucleic Acids Symp Ser (1991) 0.77
Involvement of the D-stem of tRNAPhe (E. coli) in interaction with phenylalanyl-tRNA synthetase as shown by chemical modification. FEBS Lett (1975) 0.77
Sequence-specific cleavage of single-stranded DNA by oligonucleotides conjugated to bleomycin. Antisense Res Dev (1992) 0.77
Structure of photoreactive binary system of oligonucleotide conjugates assembled on the target nucleotide sequence. J Biomol Struct Dyn (1999) 0.77
Tumoricidal Activity of RNase A and DNase I. Acta Naturae (2010) 0.76
New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids. Acta Naturae (2009) 0.75
Silencing of c-myc expression in tumor cells by siRNA. Nucleosides Nucleotides Nucleic Acids (2004) 0.75
Cancer incidence in USAF aircrew. Aviat Space Environ Med (1999) 0.75
Interaction of modified oligonucleotides with eukaryotic and mycoplasma cells and their fate inside the cells. Nucleic Acids Symp Ser (1991) 0.75
Interaction of cholesterol-conjugated alkylating oligonucleotide derivatives with cellular biopolymers. FEBS Lett (1992) 0.75
New reagent for protein-DNA contacts footprinting. Nucleosides Nucleotides Nucleic Acids (2003) 0.75
Oligo(A), oligo(TG), and Alu repeats of DNA in chromatin are available for sequence-specific chemical modification with oligodeoxynucleotide derivatives. Antisense Res Dev (1994) 0.75
Specificity of interaction of pyrimidine oligonucleotides with DNA at acidic pH in the presence of magnesium ions: affinity modification study. Antisense Res Dev (1993) 0.75
Ethidium and azidoethidium oligonucleotide derivatives: synthesis, complementary complex formation and sequence-specific photomodification of the single-stranded and double-stranded target oligo- and polynucleotides. J Mol Recognit (1994) 0.75
Interaction of keratin K1 with nucleic acids on the cell surface. Biochemistry (Mosc) (2003) 0.75
A method for generating selective DNA probes for the analysis of C-negative regions in human chromosomes. Cytogenet Genome Res (2011) 0.75
Equilibrium screening-dialysis investigation of the nucleotide sequences in the tRNAPhe recognized by phenylalanyl-tRNA synthetase (Escherichia coli). FEBS Lett (1978) 0.75
Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR by antisense oligonucleotides. Virus Genes (1995) 0.75
Refined high-field NMR solution structure of a binary-addressed pyrene/perfluoro-azide complementary DNA oligonucleotide system shows extensive distortion in the central nick region. J Biomol Struct Dyn (1999) 0.75
Sensitized photomodification of single-stranded DNA by a binary system of oligonucleotide conjugates. Antisense Nucleic Acid Drug Dev (1997) 0.75
DNA in chromatin is available for sequence-specific chemical modification with oligonucleotide derivatives. Nucleic Acids Symp Ser (1991) 0.75
Affinity modification of human chromatin with reactive derivatives of oligonucleotides. FEBS Lett (1992) 0.75
Activation of spleen lymphocytes by plasmid DNA. Vaccine (1999) 0.75
Endogenous oligonucleotides of human milk and their possible biological function. Biochemistry (Mosc) (1999) 0.75
Sequence specific chemical modification of single- and double-stranded DNA fragments with reactive oligonucleotide derivatives. Nucleic Acids Symp Ser (1991) 0.75
Oxidative DNA cleavage by free and oligonucleotide-conjugated O-bromobenzoic acid in the presence of copper(II) ions. Nucleosides Nucleotides Nucleic Acids (2004) 0.75
Complementary addressed modification of nucleic acids with the alkylating derivatives of oligothymidylate ethyl phosphotriesters. Effect of the phosphotriester fragments' configuration. FEBS Lett (1988) 0.75
[Sequence-specific interaction of pyrimidine oligonucleotides with double-stranded DNA at acidic pH complexes of different types]. Bioorg Khim (2009) 0.75
Cell surface oligonucleotide-binding proteins of human squamous carcinoma A431 cells. Nucleosides Nucleotides Nucleic Acids (2003) 0.75
Suppression of influenza virus biopolymers functions and reproduction of the virus by oligodeoxynucleotide derivatives. Nucleic Acids Symp Ser (1991) 0.75
Perfluoroarylazide derivatives of 2'-O-modified oligoribonucleotides: efficient reagents for RNA photomodification. Nucleosides Nucleotides Nucleic Acids (2005) 0.75
Synthesis and transfection activity of novel galactosylated polycationic lipid. Bioorg Med Chem Lett (2011) 0.75
c-fos protooncogene transcription can be modulated by oligonucleotide-mediated formation of triplex structures in vitro. Eur J Biochem (1996) 0.75
Structural and dynamic aspects of recognition between tRNAs and aminoacyl-tRNA synthetases. Mol Biol Biochem Biophys (1980) 0.75
C-fos gene expression in spontaneously transformed mouse fibroblast cell lines. Nucleic Acids Symp Ser (1991) 0.75
New porphyrin-linked oligonucleotide derivatives for sequence-specific chemical modification of DNA. Nucleic Acids Symp Ser (1991) 0.75
Codon--anticodon interaction in Escherichia coli tRNAPhe. Chemical modification study. FEBS Lett (1980) 0.75
Formation of nucleosomes does not suppress interaction of a DNA fragment with an alkylating derivative of a pyrimidine oligonucleotide. Antisense Nucleic Acid Drug Dev (1999) 0.75
Sequence-specific alkylation of dsDNA with derivatives of pyrimidine oligonucleotides conjugated to 2-chloroethylamine groups. Antisense Res Dev (1991) 0.75
Affinity modification of chromatin proteins located near open oligo(dA), oligo(dTG) and Alu-DNA sequences. Nucleic Acids Symp Ser (1991) 0.75
Cu(2+)-dependent DNA-cleaving activity of arenes. Nucleosides Nucleotides Nucleic Acids (2001) 0.75
The extracellular domain of CD4 receptor possesses a protein kinase activity. FEBS Lett (1998) 0.75
Glyceraldehyde-3-phosphate dehydrogenase is responsible for intranuclear localization of some oligonucleotides. Nucleosides Nucleotides Nucleic Acids (2001) 0.75